Semi-Annual Statement Of Income And Retained Earnings

SymBio Pharmaceuticals Limited - Filing #7272884

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-3,876,971,000 JPY
-3,979,914,000 JPY
-852,107,000 JPY
-811,668,000 JPY
Non-operating income
Non-operating income
224,722,000 JPY
214,783,000 JPY
135,537,000 JPY
132,789,000 JPY
Non-operating expenses
Non-operating expenses
37,186,000 JPY
37,186,000 JPY
57,252,000 JPY
57,252,000 JPY
Ordinary profit (loss)
-3,689,435,000 JPY
-3,802,316,000 JPY
-773,822,000 JPY
-736,130,000 JPY
Extraordinary income
Extraordinary income
14,298,000 JPY
14,298,000 JPY
101,333,000 JPY
101,333,000 JPY
Extraordinary losses
Extraordinary losses
131,820,000 JPY
131,820,000 JPY
560,590,000 JPY
560,590,000 JPY
Profit (loss) before income taxes
-3,806,957,000 JPY
-3,919,838,000 JPY
-1,233,079,000 JPY
-1,195,387,000 JPY
Income taxes - current
26,523,000 JPY
3,800,000 JPY
8,915,000 JPY
22,700,000 JPY
Income taxes - deferred
JPY
JPY
744,728,000 JPY
744,728,000 JPY
Profit (loss)
-3,923,638,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
-1,962,817,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.